Insight

Aug 10, 2024, 13:45

Katsuaki Maehara: EGFR mutated NSCLC

Katsuaki Maehara, Director of Medical Education Colleagues shared a post on X:

“EGFR mutated NSCLC.

This article is the latest data to analyze the concomitant driver alteration of EGFR mutated NSCLC using NGS.

It is also an important dictionary for selecting effective treatment regimens from the analysis results and for encouraging the development of combination therapies.

For all patients with EGFR mutation-positive disease.”

Source: Katsuaki Maehara/X

Landscape of Concomitant Driver Alterations in Classical EGFR-Mutated Non–Small Cell Lung Cancer.

Authors: Huaying Wang, Lie Lin, Chuqiao Liang, Jiaohui Pang, Jiani C. Yin, Junli Zhang, Yang Shao, Chengming Sun, and Renhua Guo.

Katsuaki Maehara

cancer Chengming Sun Chuqiao Liang EGFR Huaying Wang Jiani C. Yin Jiaohui Pang Junli Zhang Katsuaki Maehara Lie Lin non small cell lung cancer NSCLC OncoDaily Oncology Renhua Guo Yang Shao

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage